| Literature DB >> 34197361 |
Jonas Z Hines, Ricardo Thompson, Carlos Toledo, Robert Nelson, Isabelle Casavant, Sherri Pals, Marcos Canda, Juvencio Bonzela, Alicia Jaramillo, Judite Cardoso, Dawud Ujamaa, Stelio Tamele, Victor Chivurre, Inacio Malimane, Ishani Pathmanathan, Kristen Heitzinger, Stanley Wei, Aleny Couto, Jotamo Come, Alfredo Vergara, Duncan MacKellar.
Abstract
Male circumcision is an important preventive strategy that confers lifelong partial protection (approximately 60% reduced risk) against heterosexually acquired HIV infection among males (1). In Mozambique, the prevalence of male circumcision was 51% when the voluntary medical male circumcision (VMMC) program began in 2009. The Mozambique Ministry of Health set a goal of 80% circumcision prevalence among males aged 10-49 years by 2019 (2). CDC analyzed data from five cross-sectional surveys of the Chókwè Health and Demographic Surveillance System (CHDSS) to evaluate progress toward the goal and guide ongoing needs for VMMC in Mozambique. During 2014-2019, circumcision prevalence among males aged 15-59 years increased 42%, from 50.1% to 73.5% (adjusted prevalence ratio [aPR] = 1.42). By 2019, circumcision prevalence among males aged 15-24 years was 90.2%, exceeding the national goal (2). However, circumcision prevalence among males in older age groups remained below 80%; prevalence was 62.7%, 54.5%, and 55.7% among males aged 25-34, 35-44, and 45-59 years, respectively. A multifaceted strategy addressing concerns about the safety of the procedure, cultural norms, and competing priorities that lead to lack of time could help overcome barriers to circumcision among males aged ≥25 years.Entities:
Mesh:
Year: 2021 PMID: 34197361 PMCID: PMC8248593 DOI: 10.15585/mmwr.mm7026a2
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Male circumcision prevalence by sociodemographic characteristics and survey round — Chókwè Health Demographic Surveillance System, Chókwè District, Mozambique, 2014–2019
| Characteristic | Round 1 (Apr 2014–Apr 2015)
N = 1,109 | Round 2 (May 2015–Jan 2016)
N = 872 | Round 3 (Mar–Dec 2016)
N = 1,362 | Round 4 (Mar–Nov 2017)
N = 1,318 | Round 5 (Apr 2018–Mar 2019)
N = 1,176 | Round 5 versus
Round 1 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| % (95% CI) | aPR* (95% CI) | % (95% CI) | aPR* (95% CI) | % (95% CI) | aPR* (95% CI) | % (95% CI) | aPR* (95% CI) | % (95% CI) | aPR* (95% CI) | aPR* (95% CI) | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||
| 15–24 | 58.4 (54.0–63.2) | Ref | 72.0 (67.5–76.8) | Ref | 82.7 (79.8–85.7) | Ref | 84.7 (81.9–87.6) | Ref | 90.2 (88.0–92.4) | Ref | 1.47 (1.36–1.60) |
| 25–34 | 44.7 (38.3–52.2) | 0.81 (0.68–0.97) | 42.0 (34.5–51.2) | 0.62 (0.51–0.77) | 53.9 (46.8–62.2) | 0.69 (0.59–0.81) | 53.1 (45.0–62.6) | 0.68 (0.57–0.82) | 62.7 (55.6–70.6) | 0.77 (0.69–0.87) | 1.40 (1.16–1.70) |
| 35–44 | 39.6 (32.0–49.1) | 0.73 (0.58–0.93) | 46.1 (36.9–57.5) | 0.70 (0.55–0.88) | 48.6 (40.3–58.5) | 0.64 (0.52–0.78) | 45.6 (37.2–55.8) | 0.60 (0.48–0.75) | 54.5 (45.8–64.7) | 0.68 (0.57–0.82) | 1.37 (1.04–1.80) |
| 45–59 | 42.1 (34.2–51.7) | 0.78 (0.62–0.99) | 42.7 (33.8–53.9) | 0.66 (0.51–0.84) | 43.2 (35.6–52.4) | 0.59 (0.47–0.72) | 49.5 (41.2–59.3) | 0.67 (0.55–0.81) | 55.7 (47.1–66.0) | 0.71 (0.59–0.85) | 1.33 (1.02–1.73) |
|
| |||||||||||
| Nonsingle† | 41.6 (37.3–46.4) | Ref | 44.0 (38.9–49.8) | Ref | 51.0 (46.2–56.4) | Ref | 52.4 (47.5–57.9) | Ref | 57.6 (52.6–63.0) | Ref | 1.42 (1.31–1.53) |
| Single | 59.8 (55.3–64.6) | 1.12 (0.97–1.29) | 70.1 (65.4–75.1) | 1.18 (1.03–1.36) | 76.7 (73.2–80.3) | 1.14 (1.01–1.28) | 80.1 (76.7–83.7) | 1.12 (1.01–1.26) | 87.5 (84.8–90.2) | 1.08 (0.99–1.17) | 1.48 (1.29–1.69) |
|
| |||||||||||
| Rural | 37.0 (33.1–41.3) | Ref | 46.5 (42.2–51.2) | Ref | 57.9 (54.4–61.6) | Ref | 59.2 (55.7–63.0) | Ref | 62.5 (58.6–66.7) | Ref | 1.77 (1.58–1.99) |
| Urban | 56.7 (52.4–61.5) | 1.55 (1.36–1.76) | 62.6 (57.5–68.0) | 1.36 (1.21–1.52) | 69.4 (65.2–73.9) | 1.18 (1.10–1.26) | 70.3 (65.9–74.9) | 1.15 (1.08–1.23) | 79.1 (75.3–83.2) | 1.17 (1.11–1.23) | 1.34 (1.24–1.45) |
Abbreviations: aPR = adjusted prevalence ratio; CI = confidence interval; N/A = not applicable; Ref = referent group.
*Adjusted for age group, marital status, and urban or rural residence.
† Nonsingle was a composite variable of married, union, divorced, separated, and widowed.
§ Rural indicates residence in one of seven district villages; urban indicates residence in Chókwè town.
Knowledge, attitudes, and beliefs related to circumcision among males aged 25–59 years and females aged 15–59 years – Chókwè Health Demographic Surveillance System (Round 5), Chókwè District, Mozambique, April 2018–March 2019
| Sex, circumcision status, and beliefs | % (95% CI) |
|---|---|
|
| |
|
| |
| Underwent MC in the past year | 3.0 (1.4–6.3) |
| Know that MC is partially protective against HIV infection | 85.4 (80.5–90.5) |
|
| |
| Intend to undergo MC in the next year | 44.7 (37.6–53.0) |
| Know that MC is partially protective against HIV infection | 70.5 (63.4–78.5) |
| Reason for not undergoing circumcision* | |
| Any reason | >99.5% (NC) |
| Other† | 55.5 (48.4–63.7) |
| Fear of complications§ | 26.6 (20.5–34.4) |
| Not part of my culture | 17.2 (12.3–24.1) |
| Lack of time | 17.0 (12.1–23.9) |
| Risk for injury to penis | 13.3 (9.1–19.4) |
| Pain caused by procedure | 9.3 (5.7–15.2) |
| Risk for infection | 6.4 (3.5–11.4) |
| Does not prevent STI | 1.9 (0.6–6.3) |
| Does not prevent HIV | 1.9 (0.6–6.3) |
| Risk for impotence | 0.6 (0.1–2.4) |
| Costs too much money | 0.6 (0.1–2.4) |
| Sex is worse/less pleasurable | <0.5 (NC) |
| Partner does not want me to be circumcised | <0.5 (NC) |
| Looks unnatural | <0.5 (NC) |
| Risk for infertility | <0.5 (NC) |
| Contrary to my religious beliefs | <0.5 (NC) |
|
| |
| Believe males should be circumcised | 96.0 (95.1–96.9) |
| Ever discussed circumcision with a male sex partner or male friend or family member | 29.2 (27.2–31.4) |
Abbreviations: CI = confidence interval; MC = medical circumcision; NC = not calculated; R5 = round five; STI = sexually transmitted infection.
* Participants could indicate multiple reasons. All participants during R5 (April 2018–March 2019) indicated at least one reason why they did not undergo circumcision.
† ”Other” reason for not undergoing circumcision was a free text field. No data existed for 50.5% of responses (unweighted). Of responses with data, lack of time was the most common reason for not undergoing circumcision (32.0% of unweighted data).
§ Composite variable combining risk for injury to penis, risk for infection, or pain caused by procedure.
FIGUREHIV prevalence among males aged 15–59 years, by circumcision status and survey round*, — Chókwè Health Demographic Surveillance System, Chókwè District, Mozambique, 2014–2019
Abbreviations: aPR = age-adjusted prevalence ratio; CI = confidence interval; R = round.
* R1: April 2014–April 2015; R2: May 2015–January 2016; R3: March–December 2016; R4: March–November 2017; R5: April 2018–March 2019.
† aPRs (95% CIs) were calculated by survey round: R1 = 0.67 (0.51–0.89); R2 = 0.55 (0.40–0.76); R3 = 0.62 (0.46–0.83); R4 = 0.65 (0.49–0.88); and R5 = 0.81 (0.60–1.11).